Framer, Adele

Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023) · CNS Drugs

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 76

Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum

Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 74

What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications

Framer, A. (2021) · Therapeutic Advances in Psychopharmacology

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 73

Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnership

Boland, M., Higgins, A., Beecher, C., Bracken, P., Burn, W., Cody, A., Framer, A., Gronlund, T., Horowitz, M., Huff, C., et al. (2024) · BMJ Open

Mental Health and Patient InvolvementMental Health Treatment and Access

Cited by 14

Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms

Abie Horowitz, M., Framer, A., Strang, J., & Taylor, D. (2025) · Therapeutic Advances in Psychopharmacology

Opioid Use Disorder TreatmentPain Management and Opioid Use

Cited by 0

Pharmacological principles for safe benzodiazepine and Z-drug dose reduction

Horowitz, M., Lamberson, N., Brandt, J., Framer, A., Shapiro, B., Sørensen, A., Cadogan, C., Ritvo, A., & Taylor, D. (2026) · Psychological Medicine

Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes

Cited by 0